Patient stories

3 real journeys

Video

Real caseUnited States

Larry Black, Los Angeles: a CAR-T infusion in Shenzhen after U.S. options ran out

Larry BlackAdvanced gastroesophageal-junction adenocarcinoma with peritoneal metastasis

A Los Angeles man with advanced gastroesophageal-junction cancer flew 11,600 km to Shenzhen for China’s newly approved solid-tumor CAR-T. After the infusion his tumour marker CA19-9 fell from 8,200 to 57.6 U/mL and he was discharged.

The University of Hong Kong-Shenzhen Hospital (International Medical Center)Shenzhen

Real caseUnited States

Crossing the Pacific to Hangzhou: a first solid-tumour CAR-T case for Zhejiang

A Chinese-American patientAdvanced gastric cancer with widespread peritoneal metastasis

After multi-line treatment in the U.S. failed, a Chinese-American patient with advanced gastric cancer received satri-cel at Sir Run Run Shaw Hospital, tolerated it well and flew home.

Sir Run Run Shaw HospitalHangzhou

Real caseUnited States

Daniel: from MD Anderson to Shanghai for ivonescimab, through an ICU scare to stability

DanielAdvanced non-small cell lung cancer, with Parkinson’s disease

A U.S. patient in his 70s with advanced lung cancer and Parkinson’s disease, out of standard options at MD Anderson, chose Shanghai for the PD-1/VEGF bispecific antibody ivonescimab. After an immune-related ICU episode his condition stabilised.

Jiahui International Cancer Center (Shanghai Jiahui International Hospital)Shanghai

Each story is one person’s reported experience, not a promise of results. Outcomes differ with diagnosis and the individual. This is not medical advice; treatment decisions are made with the treating hospital.